In the brain tumor context, our evidence supports an oncogenic role also for PLAGL1, which is further substantiated by the recent discovery of recurrent PLAGL1 fusions in a subset of pediatric-type supratentorial neuroepithelial tumors [54]. This evidence concerns the gene PLAGL1 and brain neoplasm.